US Patent Issued to Dana-Farber Cancer Institute on May 26 for "Pyrazolopyridine inhibitors of c-Jun-n-Terminal kinases and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,453, issued on May 26, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Pyrazolopyridine inhibitors of c-Jun-n-Terminal kinases and uses thereof" was invented by Nathanael S. Gray (Boston), Tinghu Zhang (Brookline, Mass.), Yao Liu (Brookline, Mass.) and Yang Gao (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopologues, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or preventing disea...